WASHINGTON, Dec. 23 -- Drug Enforcement Administration has issued a rule called: Schedules of Controlled Substances: Placement of N-Desethyl Isotonitazene and N-Piperidinyl Etonitazene in Schedule I.

The rule was published in the Federal Register on Dec. 23 by Leslie Mayer, Federal Register Liaison Officer, Drug Enforcement Administration.

Summary: With the issuance of this final order, the Administrator of the Drug Enforcement Administration is permanently placing N-ethyl-2-(2-(4-isopropoxybenzyl)-5-nitro-1 H-benzimidazol-1-yl)ethan-1-amine (other name: N-desethyl isotonitazene) and 2-(4-ethoxybenzyl)-5-nitro-1-(2-(piperidin-1-yl)ethyl)-1 H-benzimidazole (other names: N-piperidinyl etonitazene; etonitazepipne), including their isomers, e...